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ABSTRACT 
The disease Amavata is the most common crippling and disabling disorder. The clinical research on Amavata has been under taken at different centers. Drugs 
are available to ameliorate the symptoms of inflammation in the form of NSAIDS (Non-steroidal anti inflammatory drugs) and long term suppression is 
achieved by DMARDS(Disease modifying anti rheumatic drugs). But most of them have gastro intestinal side effects and toxicity. Sunti and vrudhadarumoola 
churnas are very effective in pacifying digestive disorders simultaneously relieving pain. Amavata is a global problem which is increasing with the change of 
dietary habits, social structure and life style. The objective of this study is to find a cost-effective remedy to Amavata. Hence Sunti and Vrudhadaru churnas 
are selected for a comparative study of their efficacy in Amavata management. 30 patients were selected  between 20-30 years of age out of whom 15 patients 
were taken for clinical trial with Suntichurna under group‘A’ and the remaining 15 patients were taken for clinical trials with Vrudhadarumoolachurna under 
group ‘B’. The laboratory investigations were done before and after treatment. Prepared churnas of 500gms each were given, thrice daily, with lukewarm 
water after light meal for 21 days. The drugs Sunti and Vrudhadaru churna showed encouraging results as the drugs are having deepana, and panchana karmas 
which improves agni and amapachana. During treatment no side effects were noted. The aim of treatment is to prevent the production of ama and to improve 
pachana at dhatu level. Both the drugs were found to be effective in relieving the symptoms of Amavata thus fulfilling the aim.    
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INTRODUCTION 
Plants and their parts have become indispensable unavoidable 
materials for survival of human being, its influence in extend 
from  food  to  the  prevention  and  are  of  diseases. 
1and2 
Ayurveda, the pioneer of every medicinal science has its own 
views to mitigate on diseases as  well as the prevention of 
them. The word Amavatha is a self explanatory term which 
indicates  ama  and  Vata  are  the  most  important  factors  in 
etiopathogenisis of the disease 
.3 The disease Amalavatha is 
the most crippling and disabling disorder was first coined in 
Madhava Nidana only.
4 As the dietary habits, social structure 
and  life  style  has  been  changing,  occurrence  of  disease 
prevailed  more.  In  light  of  present  day  science  Amavata 
appears to be a group of Rheumatic or inflammatory musculo 
skeletal disorders
5. The severity is based on condition of ama. 
Contemporary  system  of  medicines  are  available  to 
ameliorate the symptom due to inflammation in the form of 
NSAIDS  and  the  long  term  suppression  is  achieved  by 
DMARDS.  But  most  of  them  create  gastro  intestinal 
problems,  bone  marrow  suppression  hepatotoxicity  and 
nephro toxicity etc
6. In Ayurveda the treatment of the disease 
is aviate successful as it is more etiologically  oriented and 
result producing with no side effects. The preparations are 
having  properties  of  amapachana,  agnideepana, 
Vatakaphahara,Vedanasthapana  or  Soolahara, 
Shothaharaandrasayana etc.
7and  8 The Sunti and Vrudhadaru 
are most commonly used drugs in Amavatha which are the 
main ingredients of common available formulations.
9 and10 To 
establish the efficacy of two herbal drugs individually on the 
disease of Amavatha the clinical study was done. 
MATERIALS AND METHODS 
Selection of Patients: - 30 Patients suffering with Amavatha 
were selected randomly between the age group of 20-50 years 
(irrespective of sex, diet and occupation) from the O.P.D. of 
APPRC-Secunderabad.  30patients  were  divided  into  two 
groups  as  ‘A’and  ‘B’.  15patients  in  group-A  were  treated 
with Suntichurna for 21 days. In group-B 15 patients were 
treated with Vrudhadaruchurna for 21 days.  
(a) Inclusion  criteria:  -  Patients  are  having  signs  and 
symptoms of Amavata
9 and10. 
(b) Exclusion Criteria: -  
1) Age below 20yrs and above 50yrs. 
  2) Chronicity more than 10yrs. 
  3) Other systemic diseases like DM, TB etc. 
  4) Patients with Malignancies. 
 (c) Investigations:-1) C.B.P and E.S.R  
  2) CUE 
    3) RA factor 
  4) ASO titer. 
 (d) Drugs: - Sunti churna and Vrudhadaru moola churnas. . 
Both  drugs  reference  was  taken  from  the  text  Bhava 
Prakasha
11. 
 (e) Dose and Anupana: - 500mg thrice daily with lukewarm 
water after light food. 
OBSERVATIONS AND RESULTS: -  
 
Table No.1. Based on Sex 
SN  Male  Female 
1.  10  20 
Show that incidence of Amavatha in Females is greater than Male. 
 
Table No.2.  Based on age 
Sl. 
No 
Age  Medicine used  Total  Percentage 
Sunti  Vrudhadaru 
1.  21-30  4  6  10  33.33% 
2  31-40  5  5  10  33.33% 
3  4150  6  4  10  33.33% 
Total 30 patients were between the age 20-50 were recorded in different age 
groups. 
 
Table No.3.  Based on Sex 
Sl. 
No 
Sex  Medicine used  Total  Percentage 
Sunti  Vrudhedaru 
1.  Male  4  6  10  33.33% 
2  Female  11  9  20  66.66% 
Table reveals that majority of the patients were female. 
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Table No.4. Based on occupation 
Sl. 
No 
Occupation  Medicine used  Total  Percentage 
Sunti  Vrudhedaru 
1.  Business  2  3  5  16.66% 
2  Service  5  4  9  30% 
3  Labor  3  2  5  16.66% 
4  House Wife  5  6  11  36.66% 
Majority was housewives andservice man and equal number of patients were 
business man and laborers. 
 
Table No.5. Based on Shareera  prakruti 
Sl. 
No 
Prakruti  Medicine used  Total  Percentage 
Sunti  Vrudhedaru 
1.  Vata Kapha  8  8  16  53.33% 
2  Vata  3  4  7  23.33% 
3  Kapha  1  1  2  6.66% 
4  Pitta Kapha  2  1  3  10.00% 
5  VataPitta  1  1  2  6.66% 
Maximum numbers of patients were detected as vatakaphaprakruti, next to 
that Vataprakruti. The remaining almost all equal percentage in 
Kapha,Pittakapha and Vatapitta prakruti. 
 
Table No.6. Based on Lakshanas
12 
Symptoms  No. of 
Patients 
Percentage 
HastaSandhi Vedana/ Sotha  26  86.66% 
PadaSandhi Vedana/Sotha  28  93.33% 
Sira Sandhi Vedana/Sotha  2  6.66% 
GulfaSandhiVedana/ Sotha  28  93.33% 
TrikaSandhiVedana/ Sotha  30  100% 
TanuSandhi Vedana/Sotha  29  96.66% 
Uru Sandhi Vedana/Sotha  19  63.33% 
Vrischika dansavedana  15  50% 
Agni dourbalya  30  100% 
Lala prasekana  2  6.66% 
Aruchi  30  100% 
Gourvam  29  96.66% 
Utsaha hans  29  96.66% 
Vyrasyam  28  93.66% 
Daham  17  56.66% 
Bahumootrata  11  36.66% 
Kakshi Shoola  7  23.33% 
Nidralemi  24  80.00% 
Trishna  20  66.66% 
Bhrama  8  26.66% 
Hridgraham  12  40.00% 
Vidbandhata  27  90.00% 
Tadyam  28  93.33% 
Antrakoojana  13  43.33% 
Manya Sandhivedana  28  93.33% 
Jwara  19  63.33% 
 
Table No.7. Based on Involvement of Various Joints.
13and14 
Symptoms  No. of Patients  Percentage 
Pada Sandhi  28  93.33% 
Uru Sandhi  19  63.33% 
Janu Sandhi  29  96.66% 
Gulfa Sandhi  28  93.33% 
Hasta Sandhi  18  60% 
Karpoora Sandhi  15  50% 
Manibandha Sandhi  18  60% 
Prista Sandhi  28  93.33% 
Hanu Sandhi  2  6.66% 
 
 
 
 
Table No.8.   Based on Treatment with Sunti Churna (Group ‘A’) 
Result  No. of Patients  Percentage 
Cured  8  53.33% 
Relieved  7  46.66% 
 
Table No.9.  Based on Treatment with Vrudhadaru Churna (Group ‘B’) 
Result  No. of Patients present  Percentage 
Cured  9  60% 
Relieved  6  40% 
 
DISCUSSION 
Amavata is a disease characterized by amalakshanas. All the 
factors which causes the Mandagni leads to the production of 
ama,  which  causes  vitiation  of  the  doshas  and  causes  the 
disease.. This work is restricted mainly to the clinical study 
of comparative effect of the two drugs Sunti and Vrudhadaru. 
9  patients  were  curedand6  patients  were  relived  with 
suntichoornna.  8  patients  were  curedand7  patients  were 
relived with Vrudhadaruchurna. 
CONCLUSION 
The aim of treatment in Amavata is to prevent the production 
of ama and Panchna of circulated ama at dhatu level. Both 
the drugs found effective in Amavatha in reliving symptoms. 
If used longer time prevents the ama formation and helps in 
prevention of Amavatha. Both proved effective in bringing 
leucocytes  and  E.S.R  to  normal  range  and  no  side  effects 
were noted during the treatment period and showed exhalent 
symptomatic relief. 
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